Max Lab > Lab Test in Ludhiana > Lab Test in Dugri > MRD-ALL Panel
₹ 12500
10% OFF for Senior Citizens | USE CODE SS10 *
Minimal residual disease is defined as the small number of cancer cells that remain in the body after cancer treatment. Measurable or minimal residual disease (MRD) testing is used to observe whether the cancer treatment is working fine or not. It also helps to plan further treatment plans. MRD test in Dugri, Ludhianaing is mainly used in blood cancers, such as leukaemia, lymphoma, and myeloma. MRD test in Dugri, Ludhiana for acute leukaemia is the strongest independent prognostic predictor. Also, for the treatment of adult and paediatric acute lymphocytic leukaemia (ALL), MRD test in Dugri, Ludhianaing is a part of routine test in Dugri, Ludhianaing. Additionally, in relapsed settings of multiple myeloma, MRD test in Dugri, Ludhianaing is a predictor of survival outcomes. The standard procedure of the MRD test in Dugri, Ludhiana is to assess the number of myeloma cells in a bone marrow sample using techniques like genetic sequence analysis, next-generation sequencing and flow cytometry: next-generation flow.
MRD test in Dugri, Ludhiana is done to find any remaining cancer cells that may be left in small numbers. MRD lab test in Dugri, Ludhianas use sensitive methods which can find even a single cancer cell in 1 million healthy cells. MRD blood test in Dugri, Ludhianas include methods such as polymerase chain reaction (PCR), multiparametric flow cytometry, and next-generation sequencing (NGS). Such test in Dugri, Ludhianas are used after initial treatments for blood cancers like multiple myeloma. It helps to observe how well a person’s body is responding to treatment, if the person is in full remission, and to check if remission is stable or not or if there is any recurrence.
MRD test in Dugri, Ludhiana results can affect a person’s treatment by helping in making treatment decisions and improving patient outcomes as it helps in:
Minimal residual disease is defined as the small number of cancer cells that remain in the body after cancer treatment. Measurable or minimal residual disease (MRD) testing is used to observe whether the cancer treatment is working fine or not. It also helps to plan further treatment plans. MRD test in Dugri, Ludhianaing is mainly used in blood cancers, such as leukaemia, lymphoma, and myeloma. MRD test in Dugri, Ludhiana for acute leukaemia is the strongest independent prognostic predictor. Also, for the treatment of adult and paediatric acute lymphocytic leukaemia (ALL), MRD test in Dugri, Ludhianaing is a part of routine test in Dugri, Ludhianaing. Additionally, in relapsed settings of multiple myeloma, MRD test in Dugri, Ludhianaing is a predictor of survival outcomes. The standard procedure of the MRD test in Dugri, Ludhiana is to assess the number of myeloma cells in a bone marrow sample using techniques like genetic sequence analysis, next-generation sequencing and flow cytometry: next-generation flow.
MRD test in Dugri, Ludhiana is done to find any remaining cancer cells that may be left in small numbers. MRD lab test in Dugri, Ludhianas use sensitive methods which can find even a single cancer cell in 1 million healthy cells. MRD blood test in Dugri, Ludhianas include methods such as polymerase chain reaction (PCR), multiparametric flow cytometry, and next-generation sequencing (NGS). Such test in Dugri, Ludhianas are used after initial treatments for blood cancers like multiple myeloma. It helps to observe how well a person’s body is responding to treatment, if the person is in full remission, and to check if remission is stable or not or if there is any recurrence.
MRD test in Dugri, Ludhiana results can affect a person’s treatment by helping in making treatment decisions and improving patient outcomes as it helps in:
As the number of cases of COVID-19 began rising, the need for a reliable test...Read More
The Delta and Delta Plus variants of COVID-19 have been classified as “...Read More
SARS-CoV-2, like other viruses, has been evolving consistently with time, as ...Read More
The COVID-19 pandemic presented an unprecedented challenge to public health w...Read More